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Purpose: To analyze protein patterns in the aqueous humor of glaucoma patients in comparison to control subject using
two different methods.
Methods: Aqueous humor was collected from 52 patients with primary open-angle glaucoma (POAG) and from 55 control
subjects (CO). Twenty-two POAG samples and 24 CO samples were used for protein profiling through surface enhanced
laser  desorption/ionization-time  of  flight-mass  spectrometry  (SELDI-TOF-MS)  ProteinChip  arrays.  The  data  were
analyzed by multivariate statistical methods and artificial neural networks. One highly significant biomarker was identified
through matrix assisted laser desorption/ionisation time of flight-mass spectrometry (MALDI-TOF). Thirty samples from
patients with POAG and 31 control samples were analyzed through two-dimensional electrophoresis. Subsequently, the
protein spots of all gels were detected, and the two groups were compared. One spot group exhibiting clear differential
abundance was identified by mass spectrometry (electrospray ionization mass spectrometry).
Results: In the samples analyzed by SELDI-TOF-MS, about 250 protein peaks could be consistently clustered in both
groups. The analyses revealed eight biomarkers, which discriminated glaucoma from non-glaucoma controls with a
sensitivity of 90% and a specificity of 87%. These biomarkers were purified further, and one marker, which was
upregulated in glaucoma patients (p=0.006), was identified as transthyretin. The upregulation of transthyretin in POAG
patients was also confirmed by enzyme linked immunosorbent assay (ELISA; p=0.03). In all samples analyzed by two-
dimensional electrophoresis, complex protein patterns were detected in a total of 177 spot groups. The aqueous humor of
all glaucoma patients revealed some regions that were clearly different from the controls. Several spots were significantly
increased in the aqueous humor of glaucoma patients. One of the proteins that is highly abundant in the aqueous of
glaucoma patients was identified as transthyretin.
Conclusions: The aqueous humor of glaucoma patients revealed characteristic differences in protein/peptide profiles from
control  patients  using  two  different  analytical  methods,  SELDI-TOF-MS  and  two-dimensional  electrophoresis.
Interestingly, we could detect elevated transthyretin concentrations in glaucoma samples. Transthyretin might play a role
in the onset of glaucoma since it has been shown to form amyloid deposits. These particles could cause outflow obstructions
thereby increasing intraocular pressure as a possible onset mechanism.
Glaucoma is one of the major causes of visual impairment
and blindness worldwide [1]. It describes a heterogeneous
group of eye disorders that are usually characterized by typical
structural  and  functional  abnormalities  of  the  optic  disc,
retinal nerve fiber layer, and visual field. The pathogenesis
and mechanisms of glaucoma are still not fully explained.
Several possible mechanisms are discussed that include a
mechanical pressure component, vascular dysregulation [2,
3], oxidative stress [4], or an autoimmune component [5]. One
of these mechanisms could be traced through abnormalities in
the protein composition of eye tissue and aqueous humor
[6-8].
Aqueous humor, the fluid in the anterior and posterior
chamber of the eye, plays an important role in maintaining
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functions of the eye like refraction, shape, and intraocular
pressure (IOP) [9]. A block of the aqueous humor outflow can
cause an increase in IOP [10], which is the major risk factor
for  glaucoma  [11].  Since  the  eye  is  one  of  the  immune
privileged regions of the body [12], it might be very interesting
to analyze the liquid that is closer to the site of glaucoma
damage than serum. Some proteins that are upregulated in
glaucoma  patients  are  already  identified,  like
metalloproteinase [13,14].
One  of  the  challenges  of  protein  analysis  in  aqueous
humor samples is the limited amount of samples that can be
obtained from one patient. One can collect about 100–150 µl
of aqueous from one subject [15,16]. Another difficulty arises
from the low protein concentration, which is approximately
0.20–0.5 mg/ml [17]. Therefore, very sensitive methods such
as  two-dimensional  (2D)  gel  electrophoresis  and  surface
enhanced  laser  desorption/ionization-time  of  flight-mass
spectrometry (SELDI-TOF-MS) need to be used for protein
analysis in aqueous. 2D gel electrophoresis has already been
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1437used to analyze aqueous humor samples from patients with
acute corneal rejection [15] or myopia [18].
The aim of this study was to analyze the complex protein
patterns in the aqueous humor of patients with primary open-
angle  glaucoma.  We  used  SELDI-TOF-MS  and  2D  gel
electrophoresis  for  protein  separation  and  have  identified
some important proteins through mass spectrometry.
METHODS
Patient classification: All patients included in this study were
undergoing  cataract  or  glaucoma  surgery  (e.g.,
trabeculectomy)  and  had  complete  ophthalmologic
examinations  at  the  Department  of  Ophthalmology  at
University  of  Mainz  (Mainz,  Germany).  The  patient
classification was done in accordance with the guidelines of
the European Glaucoma Society [11]. The control patients
(CO, n=55) had no other ocular disorders besides cataract.
They had no history of glaucoma, no pathologic fundus, and
no elevated IOP.
The diagnostic criteria for primary open-angle glaucoma
(POAG; n=52) were the presence of glaucomatous optic disc
damage  with  corresponding  glaucomatous  changes  in  the
visual field (examined by Goldmann perimeter; Haag-Streit,
Wedel, Germany), the presence of open angles in the patient’s
eyes, and the absence of alternative causes of optic neuropathy
(e.g., infection, inflammation, meningeal disease, ischemic
disease, and compressive lesions). All POAG patients had an
intraocular pressure greater than 21 mmHg without treatment
(Goldmann  applanation  tonometer;  Haag-Streit).  The  IOP
was calculated from three separate measurements. To rule out
wrong IOP measurements, a pachymetry examination was
also done.
Sample collection: All aqueous humor samples (AH) were
collected at the beginning of the surgery. After the corneal
incision,  the  aqueous  humor  fluid  was  removed  from  the
anterior  chamber  under  sterile  conditions  by  using  a
tuberculin syringe, and 50-100 µl per sample was collected.
All  surgical  procedures  were  performed  by  experienced
ophthalmic surgeons. After removal, the AH was stored in
microtubes at −80 °C until analysis. Before sample collection,
written consent was obtained from every patient. This study
was approved by the local ethics committee and followed the
principles of the Declaration of Helsinki.
SELDI-TOF-MS  analysis:  Twenty-two  aqueous  humor
samples from POAG patients (mean age 66.4±14 years) and
24 control samples (mean age 70.5±13 years) were measured
with SELDI-TOF-MS. All samples used for the SELDI-TOF-
MS analysis were applied to two different chromatographic
surfaces,  a  weak  cation  exchange  surface  (CM10)  and  a
reversed phase chemistry hydrophobic chip (H50). AH (2 μl)
was applied on each spot and air dried. Then, 1 µl of a saturated
sinapinic acid in 50% acetonitrile/0.1% trifluoroacetic acid
was applied to each spot twice. After air drying, each spot was
processed in the ProteinChip Reader.
ProteinChip  arrays  were  analyzed  on  a  PBS-IIC
ProteinChip Reader equipped with an array autoloader using
the  ProteinChip  Software  version  3.2  (all  from  Bio-Rad,
Hercules, CA). Each array was read at two laser intensities,
low intensity to optimize for lower molecular weight proteins
and high intensity for higher molecular weight proteins. The
high intensity protocol used an average of 192 laser shots to
each spot with a laser intensity of 220 (in relative units), a
deflector setup of 2,000 Da, and a molecular weight detection
range of 3,000-200,000 Da. The focus mass was set at 20,000
Da. The detector was run at a sensitivity of nine. For low
intensity measurements, the laser intensity was set to 200 (in
relative units) and a deflector limit of 1,500 Da, and the focus
mass was set at 8,000 Da. The raw data was transferred to
CiphergenExpress 2.1 database software (Bio-Rad, Hercules,
CA) for workup and analysis. The baseline was subtracted
using a setting of 12 times the expected fitting width. Spectra
intensity was normalized using the total ion current against an
external  normalization  coefficient  according  to  the
manufacturer.
The total ion current includes the total area under the
curve including both peak area and inherent noise. Intensity
normalization was done by calculating the total ion current for
a spectrum, and the total ion current was then divided by the
number of data points for that spectrum to obtain an average
ion  current  for  each  individual  spectrum.  An  external
coefficient of 0.2 was chosen against which each spectrum
was normalized. The very low mass region contains chemical
“noise” from the matrix and was therefore excluded from the
analysis. The low mass cutoffs were 3,000 m/z for low laser
intensity measurements and 8,000 m/z for high laser intensity
measurements.
Automatic peak detection was performed using five times
the signal-to-noise ratio for the first pass of the peak detection
and two times the signal-to-noise ratio for the second pass.
The first pass uses low sensitivity to detect obvious and well
defined peaks. The second pass uses higher sensitivity settings
to search for smaller peaks with the mass values found in the
first pass.
A list of peak cluster was created from these detected
peaks. A peak cluster was created if a peak was found in 20%
of all spectra for an individual condition above the first pass
cutoff. The mass window for peak clustering was defined as
2% of the peak mass for spectra read at high laser intensity
and  0.3%  of  the  peak  mass  for  spectra  read  at  low  laser
intensity.
2D gel electrophoresis: Aqueous humor samples (30) from
POAG patients (mean age 72.6±10 years) and 31 control
samples (mean age 71.8±10 years) were separated by 2D gel
electrophoresis  as  described  previously  for  tears  [19-21].
Thirty microliters of AH were used for each separation since
this concentration resulted in the highest resolution with about
225 spots between a 10-80 kDa range and pH 4–7, which was
tested before this study.
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1438AH  was  mixed  with  100  µl  of  rehydration  buffer
containing  8  M  urea,  2%  CHAPS
(Cholamidopropyldimethylamoniopropanesulfate),  0.28%
DTT (Dithiothreitol), 0,5% immobilized pH gradient (IPG)
buffer (pH 4-7 linear), and 0.002% bromophenol blue. This
solution was used to rehydrate IPG strips with linear pH 4–7
(Immobiline  Dry-strips;  Amersham  Biosciences,  Munich,
Germany)  in  ceramic  strip  holders  for  14  h.  Isoelectric
focusing  (first  dimension)  was  performed  on  an  Ettan
IPGphor (Amersham Biosciences, Munich, Germany).
After rehydration, the IPG strips were loaded with 130 µl
sample  solution  and  electro-focused  on  experimentally
determined running conditions. Voltage increased in gradient
and in step’n’hold steps from 200 V to 8,000 V over a 9.5 h
period.
After finishing the IEF, the focused strips were incubated
in an equilibration buffer (50 mM Tris hydrochloride, 6 M
urea,  30%  glycerol,  2%  sodium  dodecyl  sulfate,  0.002%
bromphenyl blue, and 1% DTT) for the second dimension
(SDS–PAGE). The vertical SDS–PAGE was performed using
13.5% polyacrylamide gels (duration: 60 min). Molecular
mass marker proteins with a range of 10–120 kDa (Broad
Range; Bio-Rad, Munich, Germany) were run together with
each sample. The gels were visualized using a silver staining
protocol according to Oakley [22]. Gels were fixed in 50%
methanol and 5% acetic acid, and they were then washed two
times in 50% methanol and pure water to reduce background
staining. Afterwards they were shortly sensitized in 0.02%
sodium  thiosulfate  pentahydrate  and  subsequently  washed
two times before the staining reaction was started with 0.1%
silver nitrate. Finally, the gels were washed in water and
developed  in  0.04%  formalin.  The  staining  reaction  was
stopped  in  5%  acetic  acid.  A  BioDocAnalyze  system
(Biometra, Goettingen, Germany) was used to generate digital
images of the stained gels.
SELDI-TOF  measurements—The  cluster  lists
containing peak intensity values for each group were exported
as ASCII files to Statistica (version 7.1; StatSoft, Tulsa, OK).
Based on these normalized peak intensities, p values based on
t-tests  and  multivariate  analysis  of  discriminance  were
calculated.
The Statistica software performed a multivariate analysis
of discriminance based on these peak clusters and different
conditions (surface type and laser energy). This analysis of
discriminance selected eight important protein biomarkers to
discriminate between both groups.
An artificial neural network (ANN) with the panel of
these biomarkers was created. Artificial neural networks learn
through  experience  and  not  through  programming;  their
construction is comparable to that of the human brain [23].
One of the abilities of neural networks is to accurately predict
data that were not part of the training data set, a process known
as generalization. At first, a set of protein profiles was used to
train the network. Unknown spectra is then placed in the
glaucoma or non-glaucoma groups because of the criteria
learned  from  the  other  spectra.  This  network  is  typically
formed by three layers. The input layer receives information
from  outside  via  input  sources.  The  output  layer
communicates the results via dedicated output devices. A
layer of hidden units lies between them and does most of the
processing.  ANNs  can  be  used  to  distinguish  between
pathogenetic and nonpathogenetic proteins [24].
The  software  generates  a  receiver  operating
characteristics (ROC) curve, a graphical description between
sensitivity and specificity. The x-axis shows 1–specificity and
the y-axis the sensitivity. The area under the curve (AUC) is
the quality factor for this test. An ideal AUC would have an r
value of 1. If the AUC r value is below 0.5, the classification
is only done by coincidence.
2D gels—Digital images of the 2D gels were analyzed
using  ImageMasterTM  2D  Platinum  Software  (Amersham
Biosciences, Munich, Germany). A 2D gel standard pattern
of aqueous humor from a POAG patient is shown in Figure 1.
Each spot on each gel was defined as the sum of optical
densities  of  each  pixel  in  the  spot.  After  matching  and
performing a “spot normalization” on the 61 gel images by
using user-defined landmarks on the gels, we could perform
a statistical analysis (two sample Student t-tests) to find the
absolute mean spot volumes (the center values, mean 100%,
Mean Squared Deviation 100%) that showed a significant
difference between glaucoma patients and controls.
SELDI-TOF  biomarker—Protein  identification  was
performed  by  Ultraflex  MALDI-TOF  (Bruker,  Bremen,
Germany)  in  a  similar  procedure  as  described  previously
[25,26].
Figure 1. Example of a two-dimensional gel with Oakley silver
staining of aqueous humor sample from a POAG patient. The x-axis
shows the first dimension (separation by isoelectric point), and the
y-axis  shows  the  second  dimension  (separation  by  molecular
weight). The dark spots represent stained proteins.
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Data analysis: 
Protein identifications: For  identification,  the  biomarkers  were  separated  on
SDS–PAGE. The band was cut out and cut into two pieces.
From one-half the intact protein was eluted for 2 h using an
elution buffer containing 50% formic acid, 25% acetonitrile,
15% isopropanol, 10% water, and 0.1% SDS. Afterwards, this
sample was re-profiled on SELDI Chips to make sure that the
biomarker was present and highly enriched in the elution. The
other half was incubated with acetonitrile (100%) followed by
centrifugation  and  subsequent  drying  in  a  concentrator
(Eppendorf,  Hamburg,  Germany).  Afterwards,  they  were
incubated  with  trypsin  buffer  (14.8  µg/µl  in  50  mM
NH4HCO3) at 37 °C overnight. The next day, the digested gel
pieces were centrifuged, and the supernatants were collected
and  applied  onto  an  anchor  chip  target  (Bruker,  Bremen,
Germany) using cinnamic acid matrix (0.02 g cinnamic acid/
10 ml in 50% acetonitrile). The MALDI spectra obtained were
used  for  database  searches  with  MASCOT  using  NCBI
(National Institutes of Health, Bethesda, MD) and SwissProt
(Swiss  Institute  of  Bioinformatics,  Geneva,  Switzerland)
databases.
2D gel spots—Protein identification was performed as
described previously [27,28]. For these identifications, silver
staining  according  to  the  EMBL  (European  Molecular
Biology Laboratories) protocol was used since this stain is
compatible with protein analysis through mass spectrometry
[29].
Protein spots of interest were excised from the gels and
tryptically digested. The gel pieces were first equilibrated in
25 mM ammonium bicarbonate and then dried in 25 mM
ammonium bicarbonate with 50% acetonitrile and 10 mM
DTT. Afterwards, the supernatant was removed and 55 mM
iodoacetamide was added. The gel pieces were dried, and 12.5
ng/µl trypsin in 25 mM ammonium bicarbonate was added to
digest  overnight.  The  resulting  peptide  fragments  were
sequenced  and  identified  by  electrospray  ionization  mass
spectrometry  (ESI-MS/MS;  Thermo  Electron  Corporation,
Waltham,  MA).  All  MS/MS  spectra  were  converted  into
Seaquest  files  and  used  for  database  searches  with
MASCOT using NCBI and SwissProt databases.
Transthyretin detection using ELISA—The existence
of  transthyretin  proteins  in  aqueous  humor  of  glaucoma
patients was confirmed using enzyme linked immunosorbent
assay (ELISA; AssayMax Human ProAlbumin ELISA Kit,
BioCat GmbH, Heidelberg, Germany). The test was done in
accordance with the protocol of the manufacturer, and dilution
curves were done to find the right aqueous humor dilution
before  analysis.  Repeat  determinations  were  done  for  all
samples.
RESULTS
SELDI-TOF-MS analysis: Complex protein patterns could be
detected in all samples analyzed with SELDI-TOF-MS. About
250 protein peaks (mass/charge ratios) could be consistently
clustered in both groups. Figure 2 shows the gel-like views of
aqueous humor samples from POAG patients and controls.
Through multivariate statistics, highly significant differences
could be detected between the protein profiles of both groups
(p=0.000002). The average intensities of the protein profiles
for both groups measured on CM10 Chips can be seen in
Figure 3. Each Chip was measured with a high (H) and a low
(L) intensity protocol.
There were no significant differences between the mean
age of the patient groups and the protein pattern of the groups.
The  scatter-plot  in  Figure  4  reveals  the  correlation
between the intensities of peptides and proteins in the POAG
and CO groups. All points correspond to a single peptide/
protein  measured  by  SELDI-TOF-MS.  For  each  peptide/
protein the intensities in the POAG group are plotted versus
the intensities in the CO group. All dots below the black line
reveal downregulated proteins in POAG, and all points above
the line show upregulated proteins in POAG compared to
controls.
The  analyses  revealed  eight  biomarkers  that
discriminated glaucoma from non-glaucoma controls with a
sensitivity of 90% and a specificity of 87%. The area under
the curve had an r value of 0.941 (Figure 5).
2D gel analysis: We found specific 2D gel patterns with a
maximum of 225 protein spots per aqueous humor sample.
These  patterns  revealed  significant  differences  in  the
proteomic  compositions  of  the  aqueous  humor  from
individuals with POAG and without glaucoma (p<0.05).
During electrophoresis, not all compounds of AH were
fully resolved. A maximum of 225 spots of polypeptides and
proteins could be visualized on the gels in a range from 10-80
kDa and pH 4-7 by using silver staining methods. Funding et
al. [15] analyzed AH from patients with corneal rejection by
2D electrophoresis and found a similar protein pattern.
Figure 2. Gel-like views of SELDI-TOF spectra of aqueous humor
samples generated on two different chromatographic surfaces. The
protein profiles on CM10 (weak cation exchange surface) chips can
be seen on the left side and the protein profiles on H50 (reversed
phase chemistry) chips on the right side. The profiles on the top are
from control subjects and on the bottom from patients with POAG.
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assigned with a unique number to identify spots during the gel
matching process afterwards. One hundred and seventy-seven
spot groups could be matched. Gels from patients with and
without glaucoma contained predominantly the same spots,
but in POAG patients, several spots showed a more intense
staining. Consequently, there were significant differences in
spot  volumes  compared  with  those  from  controls.  The
differences in mean volume center values of spot groups 1-8
can be seen in Figure 6 as well as their localization in a
“master-gel.” Spot group 6 (molecular weight approximately
33 kDa; pH 6) showed one of the highest t-values of 2.3. In
this spot group, 51% of the POAG group (mean volume value:
444.2) do not overlap with the CO group (mean volume value:
229.7).
Spot groups 4, 7, and 8 were found in a lower molecular
weight range around 16-17 kDa (pH 4.7–5.3). They were
detectable  in  all  samples  and  carried  a  higher  amount  of
protein than all the other spot groups (Figure 6). The POAG
group showed higher mean volume value for these three spot
groups especially in spot group 8 where the POAG group
showed a mean of 618.9 in comparison to a mean of 263.4 in
the  control  group  (t-value=1.5)  Only  spot  group  5
(approximately 45 kDa, pH 5.0) showed an increased mean
spot volume for the control group of 545.3 in comparison to
a mean volume of 294.9 in the POAG group (t-value=1.4;
Figure  3.  Group  average  intensities  of  mass  spectrometry
measurements for both CO and POAG groups and different laser
energies.  The  intensities  of  the  SELDI-TOF  readings  (U)  were
plotted against the molecular weight (in Da). All measurements on
CM10 chips are shown in this graph. H: high, L: low energy. In
several regions on this graph a higher protein intensity can be seen
in the POAG group.
Figure 6). Fifty-nine percent of the CO group does not overlap
with the POAG group.
By creating synthetic gels, we could clearly visualize
differences in spot volumes. For example, synthetic gels of
spot groups 1 and 2 are shown in Figure 7 (molecular weight
area approximately 37-50 kDa; pH 5.7–5.9). While spot group
1 consisted of large, intensive spots in individual glaucoma
gels carrying a high amount of protein, spots from spot group
2 were smaller, less intensive, and not to be found on all gels.
Therefore, spot group 1 is shown with a big radius in the
synthetic gel of the POAG group (Figure 7C). Forty-four
percent of POAG is not overlapping with the CO group (t-
value=1.4). Spot group 2 in contrast is much smaller; here,
77% of POAG were not overlapping with controls.
Identifications: The SELDI-TOF-MS analysis of the aqueous
humor  protein  profiles  revealed  a  significant  upregulated
protein concentration at 14,132 Da in the POAG group in
comparison to controls (p=0.006; Figure 8). This protein peak
was detected as a biomarker through multivariate statistics
and was later significantly identified as transthyretin (TTR)
by mass spectrometry (MALDI-TOF, Mascot Score=250).
Spot groups 4 and 7 in the 2D gel analysis showed a
higher protein concentration in aqueous humor samples from
patients with POAG (Figure 6). The protein in these spots was
significantly identified as TTR by mass spectrometry (ESI-
MS/MS) with a Mascot Score of 205 and with seven peptides
sequenced.
Figure  4.  This  scatter-plot  demonstrates  the  correlation  of  the
intensities of protein patterns between patients with primary open-
angle glaucoma (POAG) and controls (CO). Spots above the line
represent protein peaks with higher intensities in the POAG group
(using SELDI-TOF analysis), dots below the line are peaks with
lower intensity in the POAG group. This graph shows that up- and
downregulated proteins were detected in aqueous humor of POAG
patients.
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protein and the POAG group a mean of 2.5 µg/ml TTR protein
detected  through  ELISA.  The  POAG  group  showed
significantly higher levels of TTR than the control group
(p=0.03; Figure 9).
DISCUSSION
Since the aqueous humor is located closer than serum to the
site of damage in glaucomatous eyes, its analysis might give
us further information about the pathogenesis of the disease.
Figure 5. The receiver operating characteristic curve for the diagnosis
of glaucoma through complex protein patterns. The groups were
discriminated with a sensitivity of 90% and a specificity of 87%. The
calculation of the area under the curve (AUC) led to an r value of
0.94. The x-axis shows 1-specificity and the y-axis the sensitivity.
Figure 6. This graph shows the localization of spot groups 1-8 in a
“master-gel” on the left side and the mean intensities of the control
(CO) and primary open-angle glaucoma (POAG) groups on the right
side. The spot groups 4, 7, and 8 existed in all samples and carried a
higher amount of protein than all other spot groups especially in the
POAG group. The only higher mean volume in controls can be seen
in spot group 5.
The quantity of proteins in the aqueous humor is very limited;
therefore, very sensitive analytical methods such as SELDI-
TOF-MS and 2D gel electrophoresis were used to compare
proteins patterns of POAG patients and controls.
Other studies also used 2D electrophoresis for aqueous
humor analysis. Funding et al. [15] analyzed the proteins in
the aqueous humor of patients with corneal rejection with 2D
electrophoresis. They found a significant difference in protein
composition in patients in comparison to control subjects,
some of the increased protein spots derived from albumin,
cytokeratin type II, and alpha1-antitrypsin. In another study,
2D  electrophoresis  was  also  used  to  analyze  AH  humor
samples, and in this case, it was in patients with myopia [18].
One of the later identified proteins using ESI-MS/MS, was
TTR,  which  was  significantly  increased  in  patients  with
myopia.  We  also  used  2D  electrophoresis  to  analyze  AH
humor samples of patients with POAG. Protein separation
through 2D electrophoresis revealed complex protein patterns
in both groups (POAG and CO). One hundred and seventy-
seven spot groups could be matched. In eight spot groups, we
found significant differences of mean spot volumes between
glaucoma patients and controls. For several spot groups such
as group 6 (approximately 33 kDa) or group 7 and 8 (both 16–
17 kDa), the POAG group showed a higher mean volume
value than the CO group (Figure 6). The mean volume value
Figure 7. Comparison of spot groups 1 and 2 (molecular weight 37.4–
49.4 kDa, IP: 5.7–5.9). A shows a synthetic gel of all aqueous humor
control samples (CO), and C shows a synthetic gel of all aqueous
samples from patients with primary open-angle glaucoma (POAG).
B shows a “real” 2D gel of an aqueous humor sample from a patient
with primary open-angle glaucoma. The circle points out spot groups
1 and 2 on this gel. Different staining intensities due to the difference
in protein concentration can be seen for spot group 1 and 2 on the
two artificial gels.
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only in spot group 5 (approximately 45 kDa; Figure 6).
Using SELDI-TOF-MS methods, we detected a highly
significant difference between protein profiles of the POAG
group and the CO group (p=0.000002). Eight biomarkers were
calculated  with  multivariate  statistical  methods  that
discriminated glaucoma from non-glaucoma controls with a
sensitivity of 90% and a specificity of 87% (Figure 5).
In  both  studies,  TTR  was  one  of  the  significantly
upregulated biomarkers in the POAG group in comparison to
the control group (p=0.006). This marker was identified with
two different methods, MALDI-TOF-MS and ESI-MS/MS.
These  results  were  also  confirmed  using  ELISA,  which
detected a significantly higher level of TTR in the POAG
group (p=0.039; Figure 9).
TTR  is  a  tetrameric  plasma  protein  and  usually
responsible for the transportation of thyroxine and retinol
[30]. Many pathologic and non-pathologic TTR variations are
already described including TTR variations with specific gene
mutations that are associated with familial amyloidosis [31].
Some of these variations were found by using IEF screening
[32]. Sometimes TTR and its variants lead to extracellular
polymerization  of  insoluble  protein  fibrils  called  amyloid
deposits.  The  mechanism  of  the  accumulation  is  still  not
known [33-35]. Our findings of increased levels of TTR in the
Figure 8. Box plot of the protein concentration of the aqueous humor
samples (mean±SE) of the control group and the primary open-angle
glaucoma  group  at  14,132  Da  from  SELDI-TOF  analysis.  This
protein was significantly upregulated in the POAG group (p=0.006)
and was identified as human transthyretin (TTR) through MALDI-
TOF.
aqueous humor of glaucoma patients indicate that this protein
might play a role in the pathogenesis of glaucoma. Interfering
protein  precipitations  of  TTR  might  cause  a  mechanical
barrier  for  aqueous  fluid  that  could  consequently  lead  to
glaucoma in some patients.
There are some theoretical explanations about elevated
TTR levels in glaucomatous AH. In animal experiments, TTR
synthesis in ciliary pigment epithelium could be shown [36].
This  location  of  TTR  synthesis  could  explain  the  local
influence of this protein in the anterior chamber of the eye
without  having  a  systemic  effect.  Another  study  on  rats
showed a widespread ocular distribution of TTR including
retinal pigment epithelium and retinal ganglion cells [37].
Possibly dying retinal ganglion cells in glaucoma patients
dispense their TTR in the AH, which leads to higher TTR
concentrations in patients. Furthermore, in an animal study,
TTR genes were shown to be expressed more in diabetic
Müller cells when compared to non-diabetic rats [38].
Transthyretin could be identified in several studies. It was
identified as a plasma biomarker in a SELDI-TOF study in
patients with rheumatoid arthritis [39]. Increased levels of
TTR have been detected in cerebrospinal fluid in a protein
complex  consisting  of  prostaglandin-d-synthase  and
transthyretin. In Alzheimer patients increased levels of TTR
have been detected in cerebrospinal fluid in a protein complex
consisting of prostaglandin-d-synthase and transthyretin or by
itself [40,41]. Other studies report lower levels of TTR in
cerebrospinal fluid of Alzheimer patients in comparison to
controls  [42].  Leptomeningeal  metastasis  of  breast  cancer
patients  showed  decreased  levels  of  TTR  [43],  and  a  2D
Figure  9.  Box  plot  of  transthyretin  concentration  measured  by
ELISA. Levels of transthyretin protein (mean±SE) were plotted for
control  subjects  (CO)  and  patients  with  primary  open-angle
glaucoma (POAG). The protein was detected using a specific ELISA.
The POAG group showed significantly higher levels of TTR then the
control group (p=0.03).
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1443electrophoresis study also showed decreased levels of TTR in
cerebrospinal fluid of Guillain-Barré syndrome patients [44].
The  findings  of  this  study  suggest  that  there  are
significant differences in the concentration of TTR in the
aqueous humor between POAG patients and controls. These
results  lead  to  the  assumption  that  there  is  a  connection
between elevated concentrations of TTR and the pathogenesis
of POAG.
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